Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dojindo Laboratories is a prominent Japanese biotechnology company that develops and manufactures high-quality chemical reagents for life science research. The company is best known for its innovative assay kits, such as the Cell Counting Kit-8 (CCK-8), which has become a global standard for measuring cell viability and cytotoxicity. Beyond cell proliferation, Dojindo provides a diverse range of products for oxidative stress detection, protein conjugation, and metabolic research. With a history dating back to 1910, the company maintains a strong focus on chemical synthesis and analytical chemistry to support scientific advancement. Dojindo operates through a network of international subsidiaries, ensuring its specialized tools are accessible to researchers in academia and the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dojindo Laboratories.